RVTY · News · 20260809N

Market Demand Trends

REVVITY, INC. · 2026-08-09 · Importance 17 · Surprise 24

Revvity reported robust demand in diagnostics and from pharmaceutical and biotechnology customers during the second quarter. Demand was particularly strong for AI-enabled drug discovery tools, supporting improving order activity in the Life Sciences segment. The company indicated that Diagnostics made a significant contribution, while Life Sciences orders improved as AI-driven drug discovery demand increased.

Key facts

• Revvity attributed the raise in its full-year outlook to robust Diagnostics performance and increasing demand from pharmaceutical and biotech sectors, particularly in AI-enabled drug discovery. source
• Revvity’s CFO highlighted improving order activity in Life Sciences, especially for AI-driven drug discovery tools. source